Transforming Drug-Resistant TB Detection with Targeted Next-Generation Sequencing - Evidence, Cost Analysis, and Implementation Considerations

Join a comprehensive webinar featuring three leading TB experts discussing the transformation of drug-resistant tuberculosis (DR-TB) detection through targeted next-generation sequencing (tNGS). Learn about clinical evidence and policy implications from Anita Suresh, explore economic analysis insights with Dr. Alice Zwerling, and understand practical implementation considerations in South Africa from Dr. Shaheed Vally Omar. Gain valuable knowledge about addressing the global TB crisis, which infected 10.6 million and claimed 1.3 million lives in 2022, through WHO-recommended tNGS technology for comprehensive DR-TB detection. Discover critical operational factors for national-level implementation, examine clinical accuracy studies, and understand cost-effectiveness analyses. The 74-minute presentation offers PACE credits upon completion and provides essential insights for healthcare professionals working to combat drug-resistant tuberculosis through advanced diagnostic methods.